News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cognoptix President And CEO Paul Hartung Named "Emerging Medical Technologies Innovator Of The Month" By Life Science Intelligence®


12/5/2013 8:03:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix President and CEO Paul Hartung has been honored as “Emerging Medical Technologies Innovator of the Month” by Life Science Intelligence® (“LSI”). The accolade comes on the heels of clinical data presented recently at the ‘Clinical Trials on Alzheimer’s Disease’ (CTAD) scientific meeting related to the strong results of a multi-site clinical trial of the Cognoptix SAPPHIRE II eye test, which is designed to identify Alzheimer’s Disease (AD) patients via a beta-amyloid (Ab) signature in their eyes.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Cognoptix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES